MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$335M
1-Year Return
7.01%
This Quarter Return
+12.19%
1 Year Return
+7.01%
3 Year Return
+65.15%
5 Year Return
+135.64%
10 Year Return
+335.37%
AUM
$2.3B
AUM Growth
+$169M
(+7.9%)
Cap. Flow
-$20.9M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
31.98%
Holding
2,376
New
33
Increased
194
Reduced
1,525
Closed
69
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$8.79M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.41M |
| 3 |
Super Micro Computer
SMCI
|
+$2.09M |
| 4 |
Flutter Entertainment
FLUT
|
+$1.37M |
| 5 |
Deckers Outdoor
DECK
|
+$974K |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$6.23M |
| 2 |
Apple
AAPL
|
+$1.65M |
| 3 |
Microsoft
MSFT
|
+$1.19M |
| 4 |
NVIDIA
NVDA
|
+$829K |
| 5 |
Meta Platforms (Facebook)
META
|
+$784K |
Sector Composition
| 1 | Technology | 25.07% |
| 2 | Financials | 10.92% |
| 3 | Healthcare | 10.68% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
1401
Ellington Financial
EFC
$1.34B
| $50.5K | ﹤0.01% |
4,277
| – | – |
|
|
CIM
1402
Chimera Investment
CIM
$1.15B
| $50.3K | ﹤0.01% |
3,638
-383
| -10% | -$5.3K |
|
1403
Repay Holdings
RPAY
$507M
| $50K | ﹤0.01% |
4,545
-213
| -4% | -$2.34K |
|
1404
Pediatrix Medical
MD
$1.45B
| $50K | ﹤0.01% |
4,982
| – | – |
|
1405
Protolabs
PRLB
$1.18B
| $49.9K | ﹤0.01% |
1,397
-189
| -12% | -$6.76K |
|
1406
Enact Holdings
ACT
$5.79B
| $49.9K | ﹤0.01% |
1,601
-299
| -16% | -$9.32K |
|
1407
Compass
COMP
$4.92B
| $49.8K | ﹤0.01% |
13,844
-1,374
| -9% | -$4.95K |
|
1408
Malibu Boats
MBUU
$629M
| $49.6K | ﹤0.01% |
1,146
| – | – |
|
1409
Fresh Del Monte Produce
FDP
$1.71B
| $49.5K | ﹤0.01% |
1,910
| – | – |
|
1410
Vir Biotechnology
VIR
$695M
| $49.3K | ﹤0.01% |
4,869
| – | – |
|
1411
Revolve Group
RVLV
$1.59B
| $49.3K | ﹤0.01% |
2,328
| – | – |
|
1412
Globalstar
GSAT
$3.79B
| $49.3K | ﹤0.01% |
2,235
-132
| -6% | -$2.91K |
|
1413
Vita Coco
COCO
$2.25B
| $49.2K | ﹤0.01% |
2,015
+164
| +9% | +$4.01K |
|
1414
Avanos Medical
AVNS
$567M
| $49.2K | ﹤0.01% |
2,471
-438
| -15% | -$8.72K |
|
1415
Comstock Resources
CRK
$4.67B
| $49.1K | ﹤0.01% |
5,292
| – | – |
|
1416
QuinStreet
QNST
$930M
| $48.7K | ﹤0.01% |
2,758
| – | – |
|
1417
Core Laboratories
CLB
$581M
| $48.6K | ﹤0.01% |
2,848
| – | – |
|
1418
89bio
ETNB
$1.2B
| $48.6K | ﹤0.01% |
4,178
+344
| +9% | +$4K |
|
1419
SiriusPoint
SPNT
$2.22B
| $48.6K | ﹤0.01% |
3,824
-155
| -4% | -$1.97K |
|
1420
Innoviva
INVA
$1.22B
| $48.5K | ﹤0.01% |
3,182
-693
| -18% | -$10.6K |
|
1421
Middlesex Water
MSEX
$971M
| $48.5K | ﹤0.01% |
923
-103
| -10% | -$5.41K |
|
1422
MacroGenics
MGNX
$100M
| $48.4K | ﹤0.01% |
3,285
| – | – |
|
1423
Regenxbio
RGNX
$465M
| $48.1K | ﹤0.01% |
2,284
| – | – |
|
1424
Aspen Aerogels
ASPN
$543M
| $48K | ﹤0.01% |
2,728
| – | – |
|
|
DCPH
1425
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $47.8K | ﹤0.01% |
3,038
| – | – |
|